Filter
915
Filtered Results: 915
Text search:
National
Institue
of
communicable
Diseases,
India
Featured
Recommendations
88
New Publications
222
Language
Document type
No document type
459
Studies & Reports
211
Guidelines
115
Manuals
69
Strategic & Response Plan
29
Training Material
14
Situation Updates
8
Fact sheets
6
Resource Platforms
4
Countries / Regions
India
124
Global
83
Bangladesh
27
South–East Asia Region
19
Nepal
18
Asia
17
South Africa
17
Latin America and the Carribbean
12
Ethiopia
12
Kenya
11
Western and Central Europe
11
Myanmar / Burma
11
Nigeria
10
Indonesia
10
Africa
9
Pakistan
9
Philippines
7
Thailand
6
Malawi
6
Uganda
6
Syria
5
Rwanda
4
USA
4
Cambodia
4
Zambia
4
Ukraine
3
Sierra Leone
3
China
3
Afghanistan
3
Mozambique
3
Tanzania
3
Congo, Democratic Republic of
3
West and Central Africa
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
East and Southern Africa
3
Brazil
3
Sri Lanka
3
Liberia
3
Ghana
2
Chile
2
Peru
2
Guinea
2
Western Pacific Region
2
North America
2
Vietnam
2
Eastern Europe
2
Moldova
2
Russia
2
Iraq
2
North Macedonia
1
Tajikistan
1
Colombia
1
Mexico
1
Cameroon
1
Iran
1
Albania
1
Senegal
1
Niger
1
Malaysia
1
Zimbabwe
1
Morocco
1
Haiti
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Turkmenistan
1
Japan
1
Maldives
1
Mauritius
1
Tunisia
1
Bolivia
1
Argentina
1
Lebanon
1
Sudan
1
Yemen
1
Greece
1
Georgia
1
Central African Republic
1
Angola
1
Bhutan
1
South Sudan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
274
Public Health
114
Clinical Guidelines
101
Key Resources
40
Women & Child Health
37
Capacity Building
16
Pharmacy & Technologies
12
Toolboxes
Mental Health
87
COVID-19
67
NCDs
66
TB
55
HIV
51
Planetary Health
45
Global Health Education
37
Disability
36
NTDs
33
Rapid Response
29
Caregiver
28
AMR
26
Health Financing Toolbox
21
Natural Hazards
10
Pharmacy
9
Specific Hazards
8
Refugee
8
Conflict
7
Polio
7
Ebola & Marburg
6
Cholera
2
Social Ethics
2
Malaria
2
Zika
1
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east Nigeria.
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...
This second edition of the “living paper” contributes to the global knowledge on how countries are responding to the pandemic by documenting real-time actions in a key area of response – that is, social protection measures planned or implemented by governments.
For the purpose of this revie...
The Philippine Government, International Non-government Organizations (INGOs) and local NGOs are all making attempts to address the impact of disasters and climate change at various levels. The Philippine Government has made significant strides in the implementation of disaster risk reduction (DRR) ...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Global Report on assistive technology
recommended
The report notes that the number of people in need of one or more assistive products is likely to rise to 3.5 billion by 2050, due to populations ageing and the prevalence of noncommunicable diseases rising across the world. The report also highlights the vast gap in access between low- and high-inc...
